We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Top Drivers of Global Laboratory Centrifuge Market

By LabMedica International staff writers
Posted on 29 Jan 2018
Print article
Image: The global laboratory centrifuge market is expected to grow steadily during the forecast period 2017-2022, driven by three main factors (Photo courtesy of Technavio Research).
Image: The global laboratory centrifuge market is expected to grow steadily during the forecast period 2017-2022, driven by three main factors (Photo courtesy of Technavio Research).
The global laboratory centrifuge market is expected to grow steadily at a CAGR of more than 5% during the forecast period 2017-2022, driven mainly by the increasing number of biotechnology and pharmaceutical research studies, growing use of molecular diagnostics in hospitals, and technological advancements.

These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

Increasing number of biotechnology and pharmaceutical research studies

The biotechnology and pharmaceutical sector is being driven by a large unmet demand for the medical needs of the people. These industries are recording consistent growth owing to the advent of new diseases and continuous drug discovery. Since innovations require better treatments and product delivery, research in these sectors acts as a backbone for these industries.

Increasing use of molecular diagnostics in hospitals

There has been an increase in the treatment of diseases at the molecular level in hospitals in order to determine diseases elaborately and provide the complete profiling of diseases. Microcentrifuges and mini centrifuges are used in large-sized hospitals and diagnostics centers to separate body fluids. The high throughput and easy maintenance of laboratory centrifuges have propelled their demand among hospitals.

Technological advancements

Laboratory centrifuges are undergoing rapid technological transformations, including changes in design and material in their interiors and rotors. Centrifuges have also witnessed changes in their structure and function. Various types of benchtop and floor standing centrifuges are available, based on their speed and functions. For instance, microcentrifuges and ultra-centrifuges provide high speed and better resolution.

Over the next few years, next-generation centrifuge systems will gain traction in the laboratory centrifuge market. The emergence of Internet of Things (IoT) has led to the introduction of smart centrifuges known as next-generation centrifuge systems, which overcome the speed, space and volume limitations of conventional centrifuge systems. Next-generation centrifuge systems also provide indications and assistance to users, and come with automatic electric brakes, speed control mechanisms, and safety features.

In 2017, the benchtop centrifuges segment held the largest share of the medical centrifuge market, as their smaller footprint and cost-effectiveness makes them an ideal solution for laboratories and diagnostics centers with space and budget constraints. The Americas is expected to be the major revenue contributor to the global laboratory centrifuge market over the forecast period. The US and Canada dominate the region’s medical centrifuge market due to the presence of several laboratories and academic institutions, and a well-established healthcare industry in these countries. Additionally, growing research activities in the Latin American countries will also fuel the growth of the laboratory centrifuge market in this region.

The laboratory centrifuge market is fragmented due to the presence of several players. A majority of the market share is held by the key players who compete with each other on the basis of price, quality, and new innovations. These players are investing heavily in R&D in order to remain competitive in the medical centrifuge market.

Related Links:
Technavio Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more